Skip to Content

Intellia Therapeutics

NTLA

Buy $NTLA at eToro
Rank 1613
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Address 40 ERIE STREET, SUITE 130, CAMBRIDGE, MA, US

Intellia Therapeutics - Key figures

Market cap 3.69 Billion
Revenue 33.05 Million
Profit -186,754,000
P/E Ratio No information
P/s Ratio 111.53
Buy $NTLA at eToro

Intellia Therapeutics - Description

Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies.

The company is headquartered in Cambridge, Massachusetts.